Clinical trial

NCT07619534

4 developments in the corpus

NCT07619534

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

JUL 27, 2026 · OBSERVATIONAL STUDY

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

ClinicalTrials.gov

Observational study collecting CSF and biospecimens from metastatic breast cancer patients to explore predictive markers; no results yet available.

PreliminaryNCT07619534

Reported

Estimated enrollment139

Primary outcome measureCollection of CSF samples

Study durationUp to 3 years

JUL 27, 2026 · OBSERVATIONAL STUDY

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

ClinicalTrials.gov

Observational study collecting CSF and biospecimens from metastatic breast cancer patients to explore predictive markers; no results yet available.

PreliminaryNCT07619534

Reported

Estimated enrollment139

Primary outcome measureCollection of CSF samples

Study durationUp to 3 years

JUL 27, 2026 · OBSERVATIONAL STUDY

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

ClinicalTrials.gov

Observational study collecting CSF and biospecimens from metastatic breast cancer patients to explore predictive markers; no results yet available.

PreliminaryNCT07619534

Reported

Estimated enrollment139

Primary outcome measureCollection of CSF samples

Study durationUp to 3 years

JUL 27, 2026 · OBSERVATIONAL STUDY

Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

ClinicalTrials.gov

Observational study collecting CSF and biospecimens from metastatic breast cancer patients to explore predictive markers; no results yet available.

PreliminaryMalignant Neoplasm of Breast National Cancer Institute (NCI)Breast Carcinoma

Reported

Estimated enrollment139

Primary outcome measureCollection of CSF samples

Study durationUp to 3 years